Pediococcus pentosaceus Engineered to Display VP28 Protein for Oral Shrimp Protection Against White Spot Syndrome Virus
Researchers have successfully engineered a non-genetically modified organism (non-GMO) strain of Pediococcus pentosaceus to display the VP28 protein on its surface. This engineered bacterium is intended for oral administration to shrimp, providing protection against the white spot syndrome virus (WSSV). WSSV is a highly contagious and deadly viral disease that causes significant economic losses in the global shrimp aquaculture industry. The VP28 protein is a key component of the WSSV envelope and is known to play a crucial role in viral infection. By displaying VP28 on the surface of Pediococcus pentosaceus, the researchers aim to stimulate an immune response in shrimp that can neutralize the virus. This approach offers a potential alternative to traditional methods of disease control, which often rely on antibiotics or chemical treatments. The development represents a novel strategy for disease prevention in aquaculture, focusing on enhancing the shrimp's natural defenses through a probiotic delivery system. Further research and trials will be necessary to validate the efficacy and safety of this method in large-scale shrimp farming operations.
This development in aquaculture disease management highlights a shift towards biological control methods, leveraging probiotic bacteria to deliver protective antigens. The strategy of using a non-GMO Pediococcus pentosaceus strain to display VP28 protein aims to elicit an immune response against WSSV without genetic modification of the shrimp themselves. This approach could circumvent regulatory hurdles and consumer concerns associated with GMOs, while potentially offering a more sustainable and environmentally friendly alternative to chemical treatments or antibiotics. The long-term success will depend on the stability of the displayed protein, the immune response elicited in shrimp, and the cost-effectiveness of large-scale production and application. Future considerations may include optimizing the dosage, delivery method, and assessing potential impacts on the shrimp gut microbiome and the broader aquatic ecosystem.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.